LIMN

Conviction 0Scan · Fri, Jun 26, 2026

Bullish belt hold

LIMN$0.1036+4.65%

ResistanceSupportVol 14

Vol MA14 1.56M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Liminatus Pharma, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)liminatuspharma.com ↗

Price0.1036

Change+4.65%

Gap-0.61%

Rel volume0.24×

Avg volume2.91M

Avg $ vol444.96K

SMA 200.1329

SMA 500.1729

SMA 2000.6937

Price vs 50-40.08%

Price vs 200-85.07%

MA stackbearish

50/200 cross—

Supertrenddown · 0.1471

RSI (14)34

MACD hist-0.00

MACD cross—

Stoch %K / %D16 / 9

ADX (14)11

+DI / −DI21 / 30

RSI divergenceBullish

MACD divergence—

ATR %+16.94%

ADR %10.39%

52w high16.60

52w low0.0990

From 52w high-99.38%

Above 52w low+4.65%

New 52w highNo

SqueezeOff

Bollinger width75.63%

%B0.21

Donchian pos7.35%

Donchian high0.2120

Donchian low0.0950

AVWAP (52w high)0.9784

vs AVWAP high-89.41%

AVWAP (52w low)0.1011

vs AVWAP low+2.51%

OBV trendDown

Chaikin MF (20)-0.16

Today vs 20d0.24×

Avg vol (14d)1.56M

Avg vol (20d)2.91M

Avg $ vol (20d)444.96K

Market cap—

RS 3m (vs SPY)-61.21%

RS 6m (vs SPY)-94.22%

RS line new highNo

Trend template0/8

Technical rank1.9

1 week-13.09%

1 month-42.44%

3 months-46.90%

6 months-85.96%

1 year-99.57%

YTD-83.83%

P/E-0.42

P/B-32.42

P/S—

P/FCF-0.43

EPS-0.4300

Div yield—

ROE—

ROA-365.79%

Debt/Eq-10.88

Current0.96

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-187.81%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value5.74M

Revenue—

Net income-1.12M

Gross profit—

Free cash flow-9.98M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out44.88M

Employees1

ListedThu, May 1, 2025

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank1.9 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish belt hold

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LIMN

All disclosures →

No recent disclosed trades by Congress in LIMN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LIMN

No recent insider (Form 4) filings in LIMN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in LIMN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.